Arsenic and alanine aminotransferase increased Patient Reports February 12, 2012

Arsenic Side Effects Report #5926589-9
Arsenic side effect was reported by a Health Professional from ITALY on Oct 01, 2008. Male patient, 75 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, electrocardiogram repolarisation abnormality, hypoxia, pco2 decreased, platelet count decreased, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN HYDROCHLORIDE, LENOGASTRIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5853385-3
Arsenic side effect was reported by a Physician from ITALY on Jan 23, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, pco2 decreased, platelet count decreased, po2 decreased. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGASTRIM. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5919004-2
Arsenic side effect was reported by a Physician from ITALY on Oct 01, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, electrocardiogram repolarisation abnormality, hypoxia, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGRASTIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5994520-6
Arsenic side effect was reported by a Physician from ITALY on Dec 04, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, pco2 decreased, platelet count decreased, po2 decreased, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGRASTIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Arsenic Side Effects Report #5081598-X
Arsenic side effect was reported by a Physician from JAPAN on July 27, 2006. Female patient, 76 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, fibrin d dimer increased, gamma-glutamyltransferase increased. Arsenic dosage: 9.285 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CEFPIROME SULPHATE, MICAFUNGIN, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4940793-8
Arsenic side effect was reported by a Physician from JAPAN on Feb 21, 2006. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Arsenic dosage: 9.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with NAFAMOSTAT MESILATE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4947831-7
Arsenic side effect was reported by a Physician from JAPAN on Mar 02, 2006. Female patient, 36 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Arsenic dosage: 8.1 MG QD INTRAVENOUS. During the same period patient was treated with CEFEPIME DIHYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, MICAFUNGIN, SULFAMETHOXAZOLE W. Patient recovered.

Arsenic Side Effects Report #5390025-4
Arsenic side effect was reported by a Health Professional from CHINA on June 29, 2007. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic failure, therapeutic agent toxicity. Arsenic dosage: 10MG IN 250ML OF 5% DEXTROSE DAILY INTRAVENOUS DRIP. Patient died.

Arsenic Side Effects Report #5390027-8
Arsenic side effect was reported by a Physician from CHINA on June 29, 2007. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic failure, therapeutic agent toxicity. Arsenic dosage: 10MG IN 250ML OF 5% DEXTROSE DAILY INTRAVENOUS DRIP. Patient died.